Affiliation: Jacobi Medical Center
- Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected childrenJacobo Abadi
Division of Infectious Diseases, Department of Pediatrics, Jacobi Medical Center and Albert Einstein College of Medicine, 1400 Pelham Parkway, Bronx, NY, USA
J Acquir Immune Defic Syndr 41:298-303. 2006..Therapy simplification by PTI may provide a practical option in patients intolerant of or failing PI-based highly active antiretroviral therapy...
- Pregnancy in women with perinatally acquired HIV-infection: outcomes and challengesUsha K Phillips
Department of Pediatrics, Divisions of Infectious Diseases, Jacobi Medical Center, Bronx, NY, USA
AIDS Care 23:1076-82. 2011..PAH women may be at a higher risk for HIV-related disease progression. This may increase vertical transmission risks. Further studies and interventions with this growing population are warranted...
- Elevated levels of vitamin B12 and folate in vertically infected children with HIV-1Zainab A Malik
Department of Pediatrics, Children s Hospital at Montefiore, Bronx, New York, USA
AIDS 23:403-7. 2009..We sought to determine the prevalence of B12 and folate deficiencies in HIV-infected children in the United States...
- Prevalence of hepatitis B and C virus infections in children infected with HIVSima Shelly Toussi
Department of Pediatrics, Children s Hospital at Montefiore, Bronx, NY 10467, USA
Clin Infect Dis 45:795-8. 2007..Hepatitis B or C was found in 13 (5.8%) of 228 children. This analysis suggests that chronic hepatitis is prevalent and should be routinely screened for in the pediatric HIV-infected population...
- Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challengeSimona Gindea
Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA
Semin Arthritis Rheum 40:201-9. 2010..To describe the unusual occurrence of systemic lupus erythematosus (SLE) with nephritis in human immunodeficiency virus (HIV)-infected individuals...
- Use of Integrase Inhibitors in HIV-Infected Children and AdolescentsWalter Dehority
Division of Infectious Diseases, Department of Pediatrics, The University of New Mexico, MSC10 5590, 1 University of New Mexico, Albuquerque, NM, 87131 0001, USA
Drugs 75:1483-97. 2015..Dolutegravir, a second-generation integrase inhibitor, is approved for those older than 12 years. This review summarizes the use of integrase inhibitors in children and adolescents, and highlights the results of recent clinical trials...
- VH3 gene expression in children with HIV infectionQing Chang
Department of Microbiology and Immunology, Bronx, NY 10461, USA
J Infect 49:274-82. 2004..To study immunoglobulin heavy chain variable region (V(H)) gene expression in HIV-uninfected (HIV-) and HIV-infected (HIV+) children...
- Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severityWassim M Ballan
Division of Experimental Medicine, Department of Medicine, University of California San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA
J Immunol 179:3362-70. 2007..This finding suggests that NK cells may have an important role in HIV-1 disease pathogenesis in HIV-1-infected children...